News tagged with brain cancer
Discovery predicts patient sensitivity to important drug target in deadly brain cancer
A recent discovery by Van Andel Research Institute (VARI) scientists enables the prediction of patient sensitivity to proposed drug therapies for glioblastoma – the most common and most aggressive malignant brain tumor ...
Feb 06, 2012 |
4 / 5 (2) |
0
|
Imaging live mouse spinal cord will aid trauma therapy
(Medical Xpress) -- To study spinal cord injuries, researchers have had to conduct exploratory surgeries on mice to determine how nerves and other cells respond after trauma. But these approaches have only ...
Jan 25, 2012 |
5 / 5 (1) |
0
|
Possible new pathway can overcome glioblastoma resistance
Glioblastoma, a lethal brain cancer, is one of the most resistant to available therapies and patients typically live approximately 15 months.
Jan 24, 2012 |
5 / 5 (1) |
0
Team finds new way to image brain tumors, predict recurrence
After people with low-grade glioma, a type of brain cancer, undergo neurosurgery to remove the tumors, they face variable odds of survival — depending largely on how rapidly the cancer recurs. Even though their doctors ...
Jan 24, 2012 |
not rated yet |
0
Rigged to explode? Inherited mutation links exploding chromosomes to cancer
An inherited mutation in a gene known as the guardian of the genome is likely the link between exploding chromosomes and some particularly aggressive types of cancer, scientists at the European Molecular Biology ...
Jan 19, 2012 |
not rated yet |
0
Cell signaling key to stopping growth and migration of brain cancer cells
Brain cancer is hard to treat: it's not only strong enough to resist most chemotherapies, but also nimble enough to migrate away from radiation or surgery to regrow elsewhere.
Jan 17, 2012 |
5 / 5 (2) |
0
|
Selectively stopping glutathione sensitizes brain tumors to chemotherapy
Brain cancer cells are particularly resistant to chemotherapy — toxins enter the cells, but before the toxins can kill, cancer cells quickly pump them back outside. In fact, brain cancer cells are even better than healthy ...
Jan 12, 2012 |
5 / 5 (1) |
0
|
Personalized gene therapies may increase survival in brain cancer patients
Personalized prognostic tools and gene-based therapies may improve the survival and quality of life of patients suffering from glioblastoma, an aggressive and deadly form of brain cancer, reports a new University of Illinois ...
Jan 09, 2012 |
not rated yet |
0
Avastin disappoints against ovarian cancer
Avastin, the blockbuster drug that just lost approval for treating breast cancer, now looks disappointing against ovarian cancer, too. Two studies found it did not improve survival for most of these patients and kept their ...
Dec 28, 2011 |
4.3 / 5 (4) |
1
Researchers discover hereditary predisposition of melanoma of the eye
Ohio State University researchers have discovered a hereditary cancer syndrome that predisposes certain people to a melanoma of the eye, along with lung cancer, brain cancer and possibly other types of cancer.
Dec 15, 2011 |
not rated yet |
0
|
When standard treatment fails: Jefferson to start unique immunotherapy for brain tumor patients
Physicians at the Jefferson Hospital for Neuroscience (JHN), the region's only dedicated hospital, are tackling a particularly aggressive brain cancer that even surgery, chemotherapy and radiation often fail to treat with ...
Dec 14, 2011 |
5 / 5 (2) |
0
University Hospitals Seidman Cancer Center tests novel drug that makes brain tumors glow hot pink
Just 24 hours after Lisa Rek sang at her niece's wedding, her husband Brad was driving her to a local hospital.
Dec 01, 2011 |
not rated yet |
0
|
New evidence links virus to brain cancer
(Medical Xpress) -- Tilting the scales in an ongoing debate, University of Wisconsin-Madison researchers have found new evidence that human cytomegalovirus (HCMV) is associated with glioblastoma multiforme ...
Nov 23, 2011 |
4.5 / 5 (6) |
0
|
FDA approves Regeneron's eye injection Eylea
(AP) -- Regulators on Friday approved Regeneron Pharmaceuticals Inc.'s drug Eylea, an injection designed to treat a common cause of blindness in older people.
Medicine & Health / Medications
Nov 19, 2011 |
5 / 5 (1) |
5
US revokes Roche's Avastin for breast cancer
US health officials on Friday revoked the authorization of Roche's Avastin for breast cancer treatment, saying it concluded the drug had "not been shown to be safe and effective for that use."
Medicine & Health / Medications
Nov 18, 2011 |
not rated yet |
0
Brain tumor
A brain tumor is an abnormal growth of cells within the brain or inside the skull, which can be cancerous or non-cancerous (benign).
It is defined as any intracranial tumor created by abnormal and uncontrolled cell division, normally either in the brain itself (neurons, glial cells (astrocytes, oligodendrocytes, ependymal cells), lymphatic tissue, blood vessels), in the cranial nerves (myelin-producing Schwann cells), in the brain envelopes (meninges), skull, pituitary and pineal gland, or spread from cancers primarily located in other organs (metastatic tumors).
Primary (true) brain tumors are commonly located in the posterior cranial fossa in children and in the anterior two-thirds of the cerebral hemispheres in adults, although they can affect any part of the brain.
In the United States in the year 2005, it was estimated there were 43,800 new cases of brain tumors (Central Brain Tumor Registry of the United States, Primary Brain Tumors in the United States, Statistical Report, 2005–2006), which accounted for 1.4 percent of all cancers, 2.4 percent of all cancer deaths, and 20–25 percent of pediatric cancers. Ultimately, it is estimated there are 13,000 deaths per year in the United States alone as a result of brain tumors.
For more information about Brain tumor, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
